Key Takeaways Retatrutide is a next-generation GLP-1 drug targeting GLP-1, GIP, and glucagon receptors
Tech-forward innovation powering digital tools and resources accessed through our award-winning app, including easy-to-use tracking tools, an AI-powered food scanner, and more
Mod GRF 1-29: 2mg runs about $33, and will last for a similar period of time
GLP-1 medications may not be suitable for individuals with: History of pancreatitis (not recommended per UK SmPCs) Severe gastrointestinal disease or gastroparesis (caution advised) Diabetic retinopathy, particularly for semaglutide (requires monitoring) Pregnancy, planning pregnancy, or breastfeeding (contraindicated
Ammonia is released as a result of the transformation of glutamine into glutamate [78, 79]